Melatonin Alleviates Liver Mitochondrial Dysfunction in Leptin-Deficient Mice.

Area of Science:

• Mitochondrial biology
• Obesity research
• Endocrinology

Background:

• Cellular bioenergetics is a key target for understanding obesity's harmful effects.
• Obesity leads to hazardous cellular adaptations requiring new therapeutic strategies.

Purpose of the Study:

• To investigate the effects of melatonin on liver mitochondrial function and lipid metabolism.
• To evaluate melatonin as a potential therapeutic agent for obesity-induced liver conditions.

Main Methods:

• Treatment of leptin-deficient (ob/ob) mice with melatonin for 4 weeks.
• Assessment of liver mitochondrial function, including ATP production, reactive oxygen species (ROS) levels, and electron transport chain (ETC) activity.
• Analysis of lipid metabolism and mitochondrial dynamics (biogenesis, fusion).

Main Results:

• Leptin deficiency caused increased liver lipid storage, mitochondrial dysfunction (impaired ATP production, ROS overproduction), and altered mitochondrial dynamics.
• Melatonin treatment ameliorated these defects, reducing the bioenergetic deficit and improving mitochondrial homeostasis.
• Melatonin alleviated alterations in ETC machinery, biogenesis, dynamics, respiration, and outer membrane permeabilization.

Conclusions:

• Melatonin effectively counteracted obesity-induced mitochondrial dysfunction and lipid accumulation in the liver.
• Melatonin demonstrates potential as a therapeutic agent for treating adipogenic steatosis and related metabolic disorders.